On Thursday, June 20, the National Institutes of Health (NIH) Office of Research on Women’s Health (ORWH) will present “TMIST: A Three-Dimensional Approach to Early Breast Cancer Detection,” the next installment in the “Women’s Health Seminar Series.”
Tomosynthesis Mammographic Imaging Screening Trial (TMIST) principal investigator Etta D. Pisano, MD, FACR, Chief of the NIH Community Oncology and Prevention Trials Research Group, Worta McCaskill-Stevens, MD, MS, and Florida International University Professor of Obstetrics and Gynecology Carolyn D. Runowicz, MD, will headline the event.
TMIST is the first large randomized, controlled trial (RCT) that seeks to identify women in which digital breast tomosynthesis (DBT) may outpace digital mammography at reducing advanced breast cancer development.
Sixty four sites are now open and accruing patients. The trial will add approximately 70 more sites and enroll 165,000 healthy women, ages 45 to 74, who are already planning to get routine mammograms.
Register here to participate in this NIH seminar.
Continuing Medical Education (CME) credits are available for this NIH seminar. Follow CME directions on the NIH registration site.
Visit acr.org/TMIST to get more information on how your practice can become a TMIST site.
Email TMIST@acr.org with any questions you may have about TMIST.